The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law BPC 157 10 mg Fair Foundations BPC 157 Peptide and Lyme Disease: Tissue Repair and Immune Support BPC 157 Nasal Spray 10mg 10 mL VPeptide BPC 157 Nasal Spray Canada: Ultra Pure Peptide for Tissue Repair, Gut & Regeneration Pathway Research